Drug major Sun Pharmaceutical Industries' subsidiary has received approval from the US health regulator for YONSA, used for treatment of a form of prostate cancer.
Sun Pharma had acquired YONSA from Churchill Pharmaceuticals and will commercialise the drug in the US.
In a regulatory filing, Sun Pharma and Churchill Pharmaceuticals, LLC said "one of Sun Pharma's wholly owned subsidiary companies has received approval from the US Food and Drug Administration (USFDA) for YONSA."
Disclaimer: No Business Standard Journalist was involved in creation of this content